New coated nail aims to improve thigh fracture healing

NCT ID NCT05276674

Recruiting now Disease control Sponsor: Zimmer Biomet Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is checking how well a special nail works for fixing thigh bone fractures. The nail has a coating designed to reduce infection. About 100 adults with thigh fractures will get this nail and be followed for a year to see if the bone heals properly and how well they can use their leg again.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: ZNN Bactiguard Retrograde Femoral Nail (a medical device coated with an antibacterial layer to reduce infection risk)
What this could lead to: If successful, this study could confirm that the Bactiguard-coated nail is a safe and effective option for fixing thigh fractures, potentially reducing infection rates.
What could go wrong: This is a post-market study, meaning the device is already approved. The main risk is that the coating may not significantly reduce infections or improve healing compared to standard nails.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FEMORAL FRACTURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Femoral Fractures femoral neck fracture

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FEMORAL FRACTURE

Contacts and locations

Locations

Hospital Universitario Ntra. Sra. de Candelaria
ACTIVE_NOT_RECRUITING

Santa Cruz de Tenerife, Tenerife, 38010, Spain
Leeds General Infirmary
RECRUITING

Leeds, LEEDS, LS1 3EX, United Kingdom
Manchester Royal Infirmary
RECRUITING

Manchester, United Kingdom
Stepping Hill Hospital
ACTIVE_NOT_RECRUITING

Stockport, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.